Practical experience is that people cycle through ADHD and depression meds. I agree that it's hard to tell what that means because we don't generally do long term double blind placebo studies.
You'd probably need a few different measures of attention/executive function and you'd need to counterbalance them across people to prevent habituation.
Given that the regulatory bodies don't require studies like this, it's unlikely to ever happen.